For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
Tax Day, Open Skies and Toyota’s Legal Tactics
Tax Day inspires out an array of protests and demonstrations. The U.S. and EU signed an “Open Skies” agreement last month, which purportedly allows airlines…
Newsletter
Unions, New Taxes and GM Crops
Andy Stern is leaving his post as head of the Service Employees International Union. The Obama Administration may soon propose a Value Added Tax (VAT).
Newsletter
Liquor Licensing, Off-label Drugs and Fannie & Freddie
A new proposal in New York to set up a “medallion” system of liquor-licensing will serve as a compromise between wine retailers and grocery store…
Op-Eds
Short-Sighted Ban Endangers Food Supply
This week, the Senate may vote on an amendment to the FDA Food Safety Modernization Act that could undermine the integrity of the U.S.
News Release
New Study Shows Benefits of “Off-Label” Promotion for Patients, Doctors
New Study Shows Benefits of “Off-Label” Promotion for Patients, Doctors Court to Weigh In on Pharmaceutical Free Speech Washington, D.C.,…
Study
Truth or Consequences
The Benefits of Off-Label Drug and Device Promotion…